159 related articles for article (PubMed ID: 10583050)
21. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Mustakallio KK
Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
[TBL] [Abstract][Full Text] [Related]
22. Twice-daily vs. once-daily inpatient dithranol for psoriasis.
Kirkup ME; Sabroe RA; Kavanagh GM; Downs AM; Sansom JE; de Berker DA; Dunnill MG; Kennedy CT; Archer CB
Clin Exp Dermatol; 2002 Nov; 27(8):695-9. PubMed ID: 12472549
[TBL] [Abstract][Full Text] [Related]
23. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
24. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
25. Irritant potential of dithranol.
Haustein UF; Lohrisch I
Dermatologica; 1986; 173(6):288-93. PubMed ID: 3817240
[TBL] [Abstract][Full Text] [Related]
26. Low-dose dithranol treatment and tape stripping induce tolerance to dithranol in a mouse ear oedema model.
Kemény L; Farkas A; Dobozy A
Br J Dermatol; 2002 May; 146(5):764-9. PubMed ID: 12000371
[TBL] [Abstract][Full Text] [Related]
27. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
28. The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis.
Ramsay B; Lawrence CM; Bruce JM; Shuster S
J Am Acad Dermatol; 1990 Jul; 23(1):73-6. PubMed ID: 2142172
[TBL] [Abstract][Full Text] [Related]
29. [Maintenance therapy of psoriasis].
Wohlrab J
Hautarzt; 2006 Aug; 57(8):661-5. PubMed ID: 16788778
[TBL] [Abstract][Full Text] [Related]
30. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
31. [Skin reaction to dithranol and its modification by the addition of tar (LCD)].
Bratzke B; Albrecht G; Orfanos CE
Hautarzt; 1987 Jun; 38(6):356-60. PubMed ID: 2958429
[TBL] [Abstract][Full Text] [Related]
32. Irritant reactions to dithranol in normal subjects and psoriatic patients.
Kingston T; Marks R
Br J Dermatol; 1983 Mar; 108(3):307-13. PubMed ID: 6830696
[TBL] [Abstract][Full Text] [Related]
33. [Effect of various kinds of tar and tar concentrations on anthralin erythema].
Wemmer U; Schulze HJ; Mahrle G; Steigleder GK
Z Hautkr; 1986 Jun; 61(12):849-52. PubMed ID: 3751210
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of dithranol inflammation by free-radical scavengers.
Finnen MJ; Lawrence CM; Shuster S
Lancet; 1984 Nov; 2(8412):1129-30. PubMed ID: 6150185
[TBL] [Abstract][Full Text] [Related]
35. Anthralin cream as short contact therapy for psoriasis.
Miller AC
Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
[TBL] [Abstract][Full Text] [Related]
36. Anthralin inflammation versus UV-erythema in psoriatics.
Schauder S; Mahrle G
Br J Dermatol; 1983 Jul; 109 Suppl 25():117-9. PubMed ID: 6860579
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
38. The effect of indomethacin on anthralin inflammation.
Ramsay B; Rice N; Lawrence C
Br J Dermatol; 1992 Mar; 126(3):262-5. PubMed ID: 1554602
[TBL] [Abstract][Full Text] [Related]
39. [The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis].
Mahrle G; Schulze HJ
Z Hautkr; 1990 Mar; 65(3):282, 285-7. PubMed ID: 2187310
[TBL] [Abstract][Full Text] [Related]
40. The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
Kersey P; Chapman P; Rogers S; Rawlins M; Shuster S
Br J Dermatol; 1981 Aug; 105 Suppl 20():64-7. PubMed ID: 6456755
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
